Bausch vows appeal after stock ravaged by patent ruling - BNN Bloomberg

South Africa News News

Bausch vows appeal after stock ravaged by patent ruling - BNN Bloomberg
South Africa Latest News,South Africa Headlines
  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 50%

Bausch Health said it plans to vigorously defend its intellectual property after a U.S. judge ruled some patents for one of its drugs were invalid.

Bausch Health Companies Inc. said it plans to vigorously defend its intellectual property after a U.S. judge ruled some patents for one of its drugs were invalid.

“We are disappointed with today's development. We strongly disagree with any conclusion that our patents are not valid and intend to file an appeal to any such order," Bausch’s Chief Executive Officer Thomas J. Appio said in a press release on Thursday.It’s been a dramatic fall from grace for Bausch, which in its former incarnation as Valeant Pharmaceuticals International Inc. briefly eclipsed Royal Bank of Canada as the nation’s largest publicly-traded company.

Another former Valeant executive and the former head of Philidor were sentenced to a year in prison in 2018 after being convicted of fraud.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BNNBloomberg /  🏆 83. in CA

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bausch Health shares cut in half after U.S. patent ruling - BNN BloombergBausch Health shares cut in half after U.S. patent ruling - BNN BloombergShares of Bausch Health Companies Inc. were decimated Thursday, falling as much as 54 per cent before being halted, after the company was dealt an unfavourable ruling in a patent dispute.
Read more »

Bausch Health shares plummet on adverse drug patent rulingBausch Health shares plummet on adverse drug patent rulingBausch Health had been embroiled in a patent fight in a Delaware court over its gastroenterology drug Xifaxan, a product of its Salix Pharmaceuticals business
Read more »

Edmonton MLA Thomas Dang makes first court appearance on charge under Health Information ActEdmonton MLA Thomas Dang makes first court appearance on charge under Health Information ActAppearing via Webex, the Edmonton\u002DSouth MLA was not asked to enter a plea Wednesday, and the case was adjourned until Aug. 24
Read more »

Physician shortage prompts virtual ER services at Bonne Bay, Rufus Guinchard Health Centre | SaltWirePhysician shortage prompts virtual ER services at Bonne Bay, Rufus Guinchard Health Centre | SaltWireCORNER BROOK, N.L. — Patients visiting the Bonne Bay and Rufus Guinchard Health Centre will be met with virtual health care services due to physician ...
Read more »

NYC Health Commissioner Wants WHO to Rename Monkeypox Because of ‘Racism and Stigma’NYC Health Commissioner Wants WHO to Rename Monkeypox Because of ‘Racism and Stigma’New York City Health Commissioner Ashwin Vasan wants the World Health Organization (WHO) to rename monkeypox because of “racism and stigma.”
Read more »

Edmonton MLA Thomas Dang makes first court appearance on charge under Health Information ActEdmonton MLA Thomas Dang makes first court appearance on charge under Health Information ActAppearing via Webex, the Edmonton\u002DSouth MLA was not asked to enter a plea Wednesday, and the case was adjourned until Aug. 24
Read more »



Render Time: 2025-04-16 15:03:59